Nasdaq

Roche awarded WHO prequalification for the cobas® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries

Every year, over 600,000 women worldwide are diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 ...
Nasdaq

Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer

More than 99 percent of cervical cancers are caused by persistent high-risk HPV infection1 Cervical cancer is nearly 100 percent preventable with proper HPV vaccination, screening and treatment; ...
FiercePharma

Pivotal Study Validates Roche's cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical

ATHENA study shows the cobas HPV Test advances the standard of care by providing valuable information on the risks associated with the genotypes which cause 70 percent of cervical cancer Results from ...
Business Insider

Roche Granted WHO Prequalification For The Cobas HPV Test

(RTTNews) - Biopharmaceutical company Roche Holding AG (RHHBY), announced on Tuesday that its cobas HPV test for use on the cobas 6800/8800 Systems has been awarded the World Health Organization (WHO) ...
The American Journal of Managed Care

Roche Molecular Diagnostic's cobas HPV Test Approved by the FDA

A test that can detect the DNA of the human papilloma virus (HPV), to confirm the need for cervical cancer screening in women 25 years and older, has gained the FDA’s support as a primary screening ...
FierceBiotech

FDA approves new streamlined workflow option for Roche's cobas HPV Test

New process allows labs to use same Pap test vial instead of transferring sample to new vial, thus simplifying workflow INDIANAPOLIS, June 26, 2013 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) ...
Becker's Hospital Review

Roche’s new HPV test earns FDA approval

The Food and Drug Administration approved the Roche cobas HPV Test to detect human papilloma virus through the use of cervical cells collected for a Pap test and stored in SurePath Preservative Fluid.
DrBicuspid

FDA approves 1st HPV test for primary cervical cancer screening

The U.S. Food and Drug Administration (FDA) has approved a human papillomavirus (HPV) DNA test for women 25 and older that can be used to determine whether these women should have additional ...
Monthly Prescribing Reference

Interim Guidance Issued for HPV Test As Pap Alternative

(HealthDay News) — The cobas human papillomavirus (HPV) test is an effective, one-test alternative to the current recommendation of screening with either a Pap test alone or a combination of the HPV ...
Yahoo

This Simple Test Could Replace the Dreaded Pap Smear

Let's be honest: Pap smears are terrible. Every year, I stare at the ceiling and try my hardest to ignore the scraping of my insides. In the age of AI chatbots and self-driving cars, how has no one ...